Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|December 21, 2023
Targeted delivery of liposomal Ribociclib to SLC7A5 transporters in breast cancer cellsMahtab Afsharzadeh, Jaleh Varshosaz, Mina Mirian, et al.
Journal of Materials Chemistry. B|January 2, 2025
Co-delivery of dasatinib and miR-30a by liposomes targeting neuropilin-1 receptors for triple-negative breast cancer therapySahel Soghrati, Jaleh Varshosaz, Mahboubeh Rostami, et al.
International Journal of Biological Macromolecules|June 19, 2022
Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclibSarvin Shirani, Jaleh Varshosaz, Mahboubeh Rostami, et al.
Toxicology Research|February 22, 2021
4-Hydroxyhalcone effects on cisplatin-induced genotoxicity modelAref Nazari, Mina Mirian, Mahmoud Aghaei, et al.
International Journal of Biological Macromolecules|March 21, 2023
Thermosensitive TMPO-oxidized lignocellulose/cationic agarose hydrogel loaded with deferasirox nanoparticles for photothermal therapy in melanomaHadis Veisi, Jaleh Varshosaz, Mahboubeh Rostami, et al.
Journal of Liposome Research|March 7, 2020
Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cellsJaleh Varshosaz, Setareh Jandaghian, Mina Mirian, et al.
Research in Pharmaceutical Sciences|December 14, 2020
The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers <i>in vitro</i>Leila Safaeian, Golnaz Vaseghi, Mina Mirian, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 1, 2019
Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular CarcinomaJaleh Varshosaz, Monireh M Fard, Mina Mirian, et al.
Pageof 8